Diabetologia:肥胖症的发病年龄、成年早期肥胖的累计暴露量和2型糖尿病的风险?

2020-04-12 MedSci原创 MedSci原创

肥胖是2型糖尿病的一个危险因素,但对于肥胖的时间和累积暴露与疾病风险的关系仍知之甚少。本研究的目的是研究成年早期的BMI轨迹、肥胖发病年龄和肥胖年龄(肥胖程度和肥胖持续时间的乘积)与随后的2型糖尿病风

肥胖是2型糖尿病的一个危险因素,但对于肥胖的时间和累积暴露与疾病风险的关系仍知之甚少。本研究的目的是研究成年早期的BMI轨迹、肥胖发病年龄和肥胖年龄(肥胖程度和肥胖持续时间的乘积)与随后的2型糖尿病风险之间的关系。

每3年通过长达19年的调查,对1996年参与澳大利亚妇女健康纵向研究(ALSWH)的18-23岁基线妇女(n = 11,192)进行随访。收集了七次自我报告的体重。由患者自行报告2型糖尿病的发病。使用生长混合模型来确定成人早期生命过程中不同的BMI轨迹。使用Cox比例危害回归模型来研究轨迹和糖尿病风险之间的关联。

在平均16年的随访中,162名(1.5%)妇女被新诊断为2型糖尿病。确定了6种不同的BMI轨迹,不同的初始BMI和不同的增长斜率有所不同。初始BMI与糖尿病风险呈正相关。我们还观察到,开始肥胖的年龄与糖尿病风险呈负相关(HR 0.87 [95% CI 0.79, 0.96]每1年增加),肥胖年龄与糖尿病风险呈正相关(p趋势<0.0001)。

研究数据揭示肥胖的时机和肥胖的累积暴露对年轻女性2型糖尿病发展的重要性,这表明预防或延迟肥胖的发作并减少肥胖的累积暴露可能会大大降低患上糖尿病的风险。

原始出处:

Juhua Luo,Allison Hodge,Age of obesity onset, cumulative obesity exposure over early adulthood and risk of type 2 diabetes

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1639422, encodeId=a21b16394223d, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Mar 08 02:43:59 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1761374, encodeId=1ddc1e6137433, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Sep 29 02:43:59 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269464, encodeId=ff88126946407, content=<a href='/topic/show?id=f6818192258' target=_blank style='color:#2F92EE;'>#肥胖症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81922, encryptionId=f6818192258, topicName=肥胖症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c66088, createdName=gao_jian4217, createdTime=Tue Apr 14 11:43:59 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620334, encodeId=3c991620334c4, content=<a href='/topic/show?id=6a2f3e9132a' target=_blank style='color:#2F92EE;'>#发病年龄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37913, encryptionId=6a2f3e9132a, topicName=发病年龄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=973220095439, createdName=showtest, createdTime=Tue Apr 14 11:43:59 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043062, encodeId=eaed1043062ab, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Apr 12 23:43:59 CST 2020, time=2020-04-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1639422, encodeId=a21b16394223d, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Mar 08 02:43:59 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1761374, encodeId=1ddc1e6137433, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Sep 29 02:43:59 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269464, encodeId=ff88126946407, content=<a href='/topic/show?id=f6818192258' target=_blank style='color:#2F92EE;'>#肥胖症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81922, encryptionId=f6818192258, topicName=肥胖症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c66088, createdName=gao_jian4217, createdTime=Tue Apr 14 11:43:59 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620334, encodeId=3c991620334c4, content=<a href='/topic/show?id=6a2f3e9132a' target=_blank style='color:#2F92EE;'>#发病年龄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37913, encryptionId=6a2f3e9132a, topicName=发病年龄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=973220095439, createdName=showtest, createdTime=Tue Apr 14 11:43:59 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043062, encodeId=eaed1043062ab, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Apr 12 23:43:59 CST 2020, time=2020-04-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1639422, encodeId=a21b16394223d, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Mar 08 02:43:59 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1761374, encodeId=1ddc1e6137433, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Sep 29 02:43:59 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269464, encodeId=ff88126946407, content=<a href='/topic/show?id=f6818192258' target=_blank style='color:#2F92EE;'>#肥胖症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81922, encryptionId=f6818192258, topicName=肥胖症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c66088, createdName=gao_jian4217, createdTime=Tue Apr 14 11:43:59 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620334, encodeId=3c991620334c4, content=<a href='/topic/show?id=6a2f3e9132a' target=_blank style='color:#2F92EE;'>#发病年龄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37913, encryptionId=6a2f3e9132a, topicName=发病年龄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=973220095439, createdName=showtest, createdTime=Tue Apr 14 11:43:59 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043062, encodeId=eaed1043062ab, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Apr 12 23:43:59 CST 2020, time=2020-04-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1639422, encodeId=a21b16394223d, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Mar 08 02:43:59 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1761374, encodeId=1ddc1e6137433, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Sep 29 02:43:59 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269464, encodeId=ff88126946407, content=<a href='/topic/show?id=f6818192258' target=_blank style='color:#2F92EE;'>#肥胖症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81922, encryptionId=f6818192258, topicName=肥胖症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c66088, createdName=gao_jian4217, createdTime=Tue Apr 14 11:43:59 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620334, encodeId=3c991620334c4, content=<a href='/topic/show?id=6a2f3e9132a' target=_blank style='color:#2F92EE;'>#发病年龄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37913, encryptionId=6a2f3e9132a, topicName=发病年龄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=973220095439, createdName=showtest, createdTime=Tue Apr 14 11:43:59 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043062, encodeId=eaed1043062ab, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Apr 12 23:43:59 CST 2020, time=2020-04-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1639422, encodeId=a21b16394223d, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Mar 08 02:43:59 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1761374, encodeId=1ddc1e6137433, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Sep 29 02:43:59 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269464, encodeId=ff88126946407, content=<a href='/topic/show?id=f6818192258' target=_blank style='color:#2F92EE;'>#肥胖症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81922, encryptionId=f6818192258, topicName=肥胖症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c66088, createdName=gao_jian4217, createdTime=Tue Apr 14 11:43:59 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620334, encodeId=3c991620334c4, content=<a href='/topic/show?id=6a2f3e9132a' target=_blank style='color:#2F92EE;'>#发病年龄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37913, encryptionId=6a2f3e9132a, topicName=发病年龄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=973220095439, createdName=showtest, createdTime=Tue Apr 14 11:43:59 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043062, encodeId=eaed1043062ab, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Apr 12 23:43:59 CST 2020, time=2020-04-12, status=1, ipAttribution=)]
    2020-04-12 misszhang

    谢谢MedSci提供最新的资讯

    0

相关资讯

JAHA: 良好的血糖控制依然是改善糖尿病患者心血管结局的抓手

心血管并发症是糖尿病患者的主要死亡原因,良好的血糖控制可改善糖尿病患者的心血管结局。

测握力,可筛糖尿病!美研究称:肌力衰减与糖尿病有关

第9版全球糖尿病地图指出,全球各国中国糖尿病未诊人数最多,达6520万。

Diabet Med:HbA1c、收缩压、甘油三酯共同“预见”糖尿病视网膜病变

根据发表于Diabet Med的一项队列研究,HbA1c、收缩压和甘油三酯升高与2型糖尿病(T2DM)视网膜病变风险增加相关,可能成为疾病进展的筛查指标,为未来开展基于风险分层的个体化筛查方案奠定基础

Diabetologia:每周一次的半胱氨酸与每日一次的卡那格列汀对2型糖尿病患者身体成分的影响?

腹腔内或内脏肥胖与胰岛素抵抗和心血管疾病风险增加有关。本研究旨在比较semaglutide 1.0 mg和canagliflozin 300 mg对持续8期IIIB患者的身体组成的影响。

疫情之下糖尿病患者的窘境

糖尿病患者是新冠肺炎高危人群,需要为他们撑起特殊保护伞。

Circulation:1型糖尿病患者心脏衰竭风险与心脏扩张有关

导言:1型糖尿病,原名胰岛素依赖性糖尿病,多发生在儿童和青少年,也可发生于任何年龄。起病比较急促,体内胰岛素相对不足,容易发生酮症酸中毒,必须使用胰岛素治疗才能获得满意疗效,否则将危及生命。